Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown

Annual savings from FDA generic drug approvals reached $5.2 billion in 2022, with total generic drug savings hitting $445 billion in 2023. See year-by-year breakdowns and how generics cut U.S. drug costs by 87%.

More